Share this post on:

Name :
Human CD22 Protein, ECD (Extracellular Domain), Fc-fusion, Recombinant

Description :
CD22 is a 130-140 kDa, single-pass type I transmembrane protein belonging to the immunoglobulin superfamily (IgSF) and sialic acid binding Ig-like lectin (SIGLEC) family. CD22 or SIGLEC2 contains 1 Ig-like V-type and 6 Ig-like C2-type domain in the extracellular region that specifically interacts with ligands carrying α2-6-linked sialic acids. Alternate splicing generates an additional isoform that lacks the 3rd and 4th Ig-like domains. CD22 is expressed on B cells and capable of modulating B cell antigen receptor (BCR)-mediated signals, as well as the generation of BCR-independent signals. CD22 is an inhibitory co-receptor of BCR and plays a critical role in establishing signalling thresholds for B-cell activation. CD22 has 3 immunoreceptor tyrosine-based inhibitory motifs (ITIMs) in its cytoplasmic region that recruits the tyrosine phosphatase Src homology 2 domain-containing phosphatase 1 (SHP-1) to ITIMs and inhibits BCR-induced Ca2+ signaling in B cells. Phosphorylation of Tyr822 within one of ITIMs is important for CD22 signal transduction through its association with the kinases Lyn, PI3-Kinase p85α, and SYK. Interaction of CD22 to ligands in trans can regulate B-cell migration as well as the BCR signaling threshold. A more complex role for CD22 has recently been described including a role in a regulatory loop that mediates basal signaling thresholds and Src-family protein tyrosine kinase (PTK) amplification after BCR ligation. CD19 regulates CD22 phosphorylation by augmenting Lyn kinase activity, while CD22 inhibits CD19 phosphorylation via SHP-1.

Gene Symbol :
The recombinant human CD22-Fc fusion protein is expressed as an 892 amino acid protein consisting of Asp20 – Thr683 region of CD22 (UniProt accession #P20273) and a C-terminal Fc fusion from human IgG1, which exists as a dimer under non-reducing condition.

NCBI Gene ID :
933

Uniprot Entry :
P20273

Construct Details :
The recombinant human CD22-Fc fusion protein is expressed as an 892 amino acid protein consisting of Asp20 – Thr683 region of CD22 (UniProt accession #P20273) and a C-terminal Fc fusion from human IgG1, which exists as a dimer under non-reducing condition.

Source :
Human cells stably expressing human CD22-Fc and growing in chemical-defined media with no animal components or antibiotics

Amino Acid Sequence: :
DSSKWVFEHPETLYAWEGACVWIPCTYRALDGDLESFILFHNPEYNKNTSKFDGTRLYESTKDGKVPSEQKRVQFLGDK NKNCTLSIHPVHLNDSGQLGLRMESKTEKWMERIHLNVSERPFPPHIQLPPEIQESQEVTLTCLLNFSCYGYPIQLQWL LEGVPMRQAAVTSTSLTIKSVFTRSELKFSPQWSHHGKIVTCQLQDADGKFLSNDTVQLNVKHTPKLEIKVTPSDAIVR EGDSVTMTCEVSSSNPEYTTVSWLKDGTSLKKQNTFTLNLREVTKDQSGKYCCQVSNDVGPGRSEEVFLQVQYAPEPST VQILHSPAVEGSQVEFLCMSLANPLPTNYTWYHNGKEMQGRTEEKVHIPKILPWHAGTYSCVAENILGTGQRGPGAELD VQYPPKKVTTVIQNPMPIREGDTVTLSCNYNSSNPSVTRYEWKPHGAWEEPSLGVLKIQNVGWDNTTIACAACNSWCSW ASPVALNVQYAPRDVRVRKIKPLSEIHSGNSVSLQCDFSSSHPKEVQFFWEKNGRLLGKESQLNFDSISPEDAGSYSCW VNNSIGQTASKAWTLEVLYAPRRLRVSMSPGDQVMEGKSATLTCESDANPPVSHYTWFDWNNQSLPYHSQKLRLEPVKV QHSGAYWCQGTNSVGKGRSPLSTLTVYYSPETSTGTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDV SHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPRE PQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFS CSVMHEALHNHYTQKSLSLSPGK

M.W. :
Calculated molecular mass (kDa): 100.2; Estimated by SDS-PAGE under reducing condition (kDa): 120-130 probably due to glycosylation

Calculated PI :
6.46

Calculated Extinction Coefficients :
(M-1 cm-1, at 280nm): 181180

Endotoxin Level :
>90% judged by SDS-PAGE under reducing condition (see the gel image above, labeled as “S” and “M” for marker)

Formulation :
Supplied at 0.5 mg/ml in sterile PBS pH7.4 (carrier & preservative free).

Endotoxin Level :
<0.1 EU per 1 μg of purified recombinant protein determined by the LAL method

Biological Activity :
Immobilized CD22 ECD protein supports the adhesion of human red blood cells. Binds anti-CD22 monoclonal antibodies (SKU#MAB1175, SKU#MAB1195) with high affinity.

Molecule Class :
1-Pass Type I Transmembrane

Gene Synonym :
<0.1 EU per 1 μg of purified recombinant protein determined by the LAL method

Gene Family :
CD22; SIGLEC2; SIGLEC-2; BL-CAM; Leu-14

Research Area :
Immunology

Pathway/Disease :
B Cell Development

Species :
Human

CD Antigen :
CD22

References :
1. Nature 345:74-77(1990) 2. J. Exp. Med. 173:137-146(1991) 3. Science 269:242-244(1995) 4. Annu. Rev. Immunol. 15:481-504(1997) 5. Immunol Rev. 230: 128-43 (2009)

MedChemExpress (MCE) recombinant proteins include: cytokines, enzymes, growth factors, hormones, receptors, transcription factors, antibody fragments, etc. They are often essential for supporting cell growth, stimulating cell signaling pathways, triggering or inhibiting cell differentiation; and are useful tools for elucidating protein structure and function, understanding disease onset and progression, and validating pharmaceutical targets. At MedChemExpress (MCE), we strive to provide products with only the highest quality. Protein identity, purity and biological activity are assured by our robust quality control and assurance procedures.
Related category websites: https://www.medchemexpress.com/recombinant-proteins.html
Popular product recommendations:
Draxin Protein
IHH Protein
Popular categories:
LAMP3/CD63
Ubiquitin Conjugating Enzyme E2 C

Share this post on: